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Assessment of body potassium stores
JOHN PATRICK
Tropical Metabolism Research Unit, University of the West Indies, Kingston, Jamaica
Ninety-five percent of body potassium is intra-
cellular where it fulfills a role with respect to intra-
cellular waler, which is analogous in many ways to
that of sodium in the extracellular water. For ex-
ample, each is the principal determinant of the
osmolality of its compartment, and the absolute
quantities of each in the organism are clearly re-
lated to the volume of the intracellular and extra-
cellular spaces. The case with which the sodium
concentration of the extracellular fluid (ECF) may
be measured contrasts markedly with the difficul-
ties of measuring directly the intracellular potas-
sium concentration. This difficulty is central to
many of the problems associated with the assess-
ment of potassium stores. Nevertheless, in the as-
sessment of potassium stores, it is not only neces-
sary to know the amount of potassium in the body
hut to be able to express this figure in a physio-
logical and meaningful way. This should ideally
include a measurement of the concentration of po-
tassium in intracellular water as well as the techni-
cally easier expression in terms of dry solids or body
weight. Furthermore, since potassium is maintained
within the cell by an active transport system which
transports sodium outwards and potassium inwards,
thus balancing "passive" leaks down the electro-
chemical gradients [1, 21, a proper appraisal of potas-
sium physiology should include an assessment of this
mechanism, both active transport and so-called pas-
sive permeability. In theory there ought to be at least
two distinct types of potassium deficit leading to a
low intracellular potassium concentration, one which
follows negative balance from, for example, severe
diarrhea, and a second which is consequent upon
altered membrane permeability or disordered func-
tion of the sodium-potassium exchange mechanism
and results from the consequent inability to retain
potassium within the cell. A third mechanism for a
reduction in total body potassium without a neces-
sary reduction in intracellular potassium concentra-
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lion is loss of lean body mass (LBM), as in muscle
wasting.
These different types of potassium deficiency and
the different modes of expression of potassium mea-
surements which are required to distinguish between
them cannot be obtained from a single methodology.
Thus, a clear formulation of the aspect of potassium
stores under study and an understanding of which
methodology will provide the answer are needed be-
fore data can be acquired and presented in an appro-
priate manner. Many of the problems and apparent
contradictions in the literature on body potassium
stores are the result of failures in formulation and
interpretation rather than errors of measurement.
For this reason this paper will detail the methods
available for the assessment of potassium stores with
particular reference to the limitations associated with
each method. A tentative approach to the assessment
of potassium stores will then be presented and its
application in clinical settings briefly demonstrated.
Methods of assessment of potassium status
Plasma potassiumn. No correlation has been found
between measurements of plasma potassium and to-
tal exchangeable potassium in a variety of diseases [3,
4]. Many of the patients studied, however, had condi-
tions or were receiving treatment now known to af-
fect the function of the sodium-potassium pump. In
simpler situations not associated with defective trans-
port or permeability disorders, a low plasma potas-
sium was found to be a feature of potassium deple-
lion [5—7]. Plasma potassium, therefore, should not
be discounted as a guide to potassium status, but it
must be supplemented with other investigatory meth-
ods. The total amount of potassium in the plasma
does correlate with total body potassium in normal
subjects [81. Furthermore, since the potassium trans-
port systems of red cells [I], leucocytes [9], and
muscle [5] are normally stimulated by potassium
(Fig. 1), with a net increase in intracellular potas-
sium (Fig. 2), some relationship between plasma
potassium and tissue potassium would be expected
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in normal subjects. There are several factors which
will tend to obscure this relationship. The variations
in plasma potassium which occur throughout the day
are so transient, relative to the time required for
new steady state levels to be achieved in the cells,
that equilibration is rarely achieved before plasma
potassium has again altered. The level of intra-
cellular sodium also varies betweeen cell types, and
this will limit the degree to which sodium and
potassium transport are stimulated by external po-
tassium. If plasma potassium were maintained for
sufficient time at steady levels, I would expect a
relationship between plasma potassium and total
body potassium (TBK) to be demonstrated.
Balance data. Elemental balance studies provide
information about net retention or loss of potassium
but cannot measure the normality or abnormality of
body potassium without making assumptions about
body composition at the beginning or end of the
study. The principles of the balance technique were
set out by Riefenstein, Albright, and Wells [101 and
the intrinsic errors recently reemphasized [11]. Over a
short period, estimates of change in body potassium
are similar whether obtained by the balance method
or repeated measurements of total exchangeable po-
tassium [7, 121. In one study over a week, 18 of 22
comparisons of balance data with repeated total ex-
changeable potassium measurements agreed to
within 125 mmoles [12]. No account of dermal losses
was taken, and this is necessary for longer balances
[13—16] because dermal losses can amount to 10
mmoles/day.
The utility of such studies was exemplified by the
reduction in mortality from infantile gastroenteritis
with potassium supplementation [17] following Dar-
row's demonstration of the need for potassium [18].
Subsequently, it has been used to demonstrate the
prolonged time-course of potassium repletion in mal-
nutrition: usually more than seven days [19] com-
pared to that following experimental potassium de-
pletion, which is usually about three days [20].
More recently, the balance method has been used
to demonstrate the interrelationships between differ-
ent minerals and nutrition, an area which is likely to
prove a fruitful area for research [2 1—23].
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Fig. I. The effect of external potassium concentration on potassium
influx in red cells (upper graph) and leukocytes (lower graph). The
upper curue in each case represents total flux and the lower curee.
glycoside insensitive flux. Note that the proportion of glycoside
insensitive flux is dilferent in the two cell types and that the so
called passive" flux is apparently a saturable process. (The upper
graph is from Glynn [140]: the lower graph is from Hilton et al [91.)
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Fig. 2. The effect of external potassium on intracellular potassium in
leukoctes. The asterisks represent cells originally incubated in
media with a potassium concentration of zero for 40 mm and then
transferred to a medium with the potassium concentration in-
dicated for 20 mm. The open circles from left to right are the mean
values from ten patients on long-term diuretic therapy, 23 maras-
mic children, and 23 undialyzed uremic patients. The marasmic
children and the uremic patients have an unusual relationship
between plasma potassium and intracellular potassium. These pa-
tients also had abnormal sodium transport.
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Potassium balance studies should be considered in
parallel with nitrogen balance data if a distinction is
to be drawn between a change in potassium balance
consequent upon an alteration in lean body mass
without any change in intracellular potassium con-
centration and a loss of potassium, unassociated with
a reduction in cell mass, so that the intracellular
potassium concentration necessarily falls. This is es-
sentially the point Scribner and Burnell were making
when they introduced the term "potassium capacity"
[24]. They defined the potassium capacity as "the
sum total of all anions and other chemical groups
outside the extracellular space capable of holding or
binding potassium ions" and postulated that "true"
potassium deficiency should be associated with spare
potassium capacity. They identified the major con-
stituents of the potassium capacity as intracellular
proteins and glycogen which are also important con-
stituents of lean body mass (LBM). Catabolism of
the LBM necessarily leads to increased potassium
excretion, and conversely, synthesis of LBM will re-
quire potassium.
The ratio of potassium to nitrogen in lean tissue is
assumed to be 3 mmoles of potassium to I g of
nitrogen [25]. Glycogen is also associated with potas-
sium in the ratio of 0.45 mmoles of potassium to I g
of glycogen. There is, therefore, approximately 100
mmoles [5, 26] of potassium associated with glycogen
which will be lost during early starvation. Thus, un-
der these circumstances the ratio between urinary
potassium and nitrogen can be much higher than 3: 1.
During a decrease in potassium capacity due to loss
of LBM, TBK will fall, but cellular concentrations of
potassium may be normal. The ratio of potassium to
nitrogen retention during resynthesis of LBM is sim-
ilar to the ratio excreted during catabolism of LBM
and often easier to study; thus, in a recent paper [211
balances of potassium relative to nitrogen varied
from 2.6 to 4.4, depending upon the nature of the
diet. The higher value followed a potassium-deficient
diet during which muscle potassium dropped by just
over 10%. The question of the relationship between
nitrogen and potassium was analyzed very elegantly
by Muntwyler and Griffin [27]. Low protein, low
potassium diets were fed to rats for five weeks
without significant change in muscle potassium
(mmoles/l00 g of fat-free dry solids [FFDS]). One
group was then refed protein without potassium.
Skeletal muscle potassium dropped from 44.2
mmoles/I00 g of FFDS to 32.9 mmoles/lOO g of
FFDS. Potassium balance remained unchanged. Un-
like the previous study [211 nitrogen retention oc-
curred despite absence of potassium, but the weight
gain was small compared to that achieved with potas-
sium and nitrogen supplementation. It is clear from
these experiments that negative whole body balance
for potassium and a fall in cellular potassium concen-
tration are not necessarily related.
Total exchangeable potassium. In normal subjects
total exchangeable potassium (Ke) measures 92 to
99% of total body potassium (TBK) at the usual
sampling time of 24 hr [28—31]. In disease states the
equilibration time may be greatly prolonged. For
example, in uremia [29], K was only 60% of TBK at
24 hr, and in another study cardiac patients required
45 hr for equilibration [32]. A decreased proportion
of exchangeable potassium was suggested as the rea-
son, but disordered transport mechanisms are at least
as likely [33—36]. In disease states evidence that Ke
measurements are taken at plateau values must be
clearly presented; otherwise, Ke measurements will
underestimate TBK. The precision of total exchange-
able potassium measurements depends upon the ref-
erence value used as well as upon the methodology
[37]. Coefficients of variation from 5 to 20% have
been reported [30, 32, 37]. In two studies [30, 38],
differences of approximately 500 mmoles were ob-
served in the same subject, depending upon whether
urine or plasma specific activity was measured. Re-
peat measurements in the same individuals led to the
conclusion that a difference of 600 mmoles was neces-
sary before a difference could be taken as reliable
[39], although another study [32] found that the
standard deviation for repeated measurements in nine
subjects was 2.6% (approximately 100 mmoles).
Total exchangable potassium measurements have
been used to distinquish whole body potassium de-
pletion with and without a fall in intracellular potas-
sium concentration. Thus, Deuxchaisnes et al [32]
noted that in wasting of muscle mass, K and Ku/kg
did not change in parallel. K/kg was normal, while
K was decreasing. The problem of interpretation is
more complex with severe wasting because this may
be associated with a low intracellular potassium in
the remaining muscle and because wasted muscle is
often replaced by fat [40], which has a low potassium
content expressed as mmoles/I00 g of wet wt. In
membrane transport diseases, K and Ke/kg will also
be reduced, but the distinction between potassium
depletion with and without membrane transport dis-
ease cannot be made with certainty from exchange-
able potassium measurements. If a prolonged equili-
bration time is demonstrated, defective transport of
potassium into the cells may be responsible, while an
increased permeability of the membrane to potassium
would theoretically lead to more rapid isotopic equi-
librium.
Whole body counting. The method was originally
described by Sievert [41] and by Burch and Spiers
[42]. Subsequently, in 1962 the technical problems
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and methodology were extensively discussed at a
symposium [43]. Since then the methodology has
been further refined [30, 31, 44—49, 52]. In conditions
with altered body composition, it is not always pos-
sible to be certain that artifacts are not introduced as
a result of the altered geometry and counting effi-
ciency [48]. Some of the most sophisticated systems
are claimed to be almost independent of geometry
problems. For example, the reproducibility of the
Brookhaven system was approximately + 3% for
body weights ranging from 26.6 to 145.5 kg [45].
There have been very few comparisons, however, of
chemical and radioactive potassium (40K) measure-
ments of total body potassium. The only study of the
human body was of two malnourished children,
where agreement between the two methods was
within 5% [49]. Counting children is probably a little
easier than adults because one such study reported
very narrow 95% confidence levels [50]. Chemical and
40K comparisons have been made in animals and have
been found to be closely correlated [44, 51]. In one
study careful construction of manikins reduced the
mean difference between chemical and 40K measure-
ments from 4.4% to 0.3%, emphasizing the impor-
tance of calibration and geometry [44]. In pigs weigh-
ing from 1.2 to 13.5 kg, 40K measurements gave a
mean value of 12.8 g/kg, compared to 13.6 g by
chemical analysis (r = 0.96) [51]. Another way to
determine counting efficiency is to give the subject a
small known dose of potassium 42 (42K), but this
method is too time consuming for most purposes.
One way around this has been to examine a group of
subjects with a wide range of body habitus and to use
the 42K method to obtain a range of calibration fac-
tors for different heights, weights, skinfold thickness,
etc., which can then be used subsequently. Although
the reproducibility in a given laboratory may be +
3%, in one interlaboratory study reproducibility var-
ied from 92 to 116% of the originating laboratory
value [47]. Considerably better interlaboratory corre-
lations have also been reported [46].
For clinical research purposes, the greatest need
has been to provide a narrow estimated normal range
for any given individual, which in reality means find-
ing the most useful reference standard. Those studied
are age, sex, weight, height, skinfold thickness, total
red cell potassium and functions of these variables.
Some of the regression equations which have been
developed are given in Table 1. The estimate for the
normal value in any given individual, however, re-
mains at + 10 to 15% [52, 53].
In summary, whole body counting can provide
information which is very accurate for following se-
quential changes, providing that calibration systems
take proper account of any changes in body composi-
tion [54]. The 40K method will also measure potas-
sium depletion and a change in potassium capacity,
but it will not distinguish between potassium loss
from disease, such as severe diarrhea and an inability
to retain potassium because of a disorder in mem-
brane transport of potassium.
Neither is it possible from whole body potassium
or exchangeable potassium measurements to obtain a
value for intracellular potassium concentration in cell
water. To do this, measurements of total body water
(TBW) and the ECF space are required. These mea-
surements, particularly that of the ECF space, are
problematical. First of all, as Table 2 indicates, the
space measured by different markers is quite variable
even in normal subjects. In disease this variability is
exaggerated. Malaria increased the thiocyanate space
to a value which approached TBW [56]. Cardio-
pulmonary bypass increased the bromide space [57].
In malnutrition, the bromide space [58] and the thio-
sulfate space [59] can be as large in marasmic chil-
dren (without edema) as in Kwashiorkor (with
edema). On a diet providing only maintenance
amounts of energy, the latter can lose 20% of body
wt with loss of edema and an appropriate reduction
in bromide space, while the marasmic children lose
virtually no weight. Some of these findings seem more
reasonable when interpreted in terms of altered
membrane permeability to the marker than when
interpreted as ECF expansion. To overcome the
problems associated with measurement of the ECF,
the assumption of a constant membrane potential
has been made and a corrected chloride space
calculated [60]. This approach is open to criticism,
because in uremia, potassium depletion, and some
severely ill patients where the membrane potential
has been shown to be altered [61—63], it is clearly
in error to assume a normal value. Because only
a small amount Qf potassium is extracellular, errors
in measuring extracellular volume (ECV) do not
critically affect the measurement of total intracel-
lular potassium. Such errors, however, do affect
the calculation of intracellular water and thus in-
fluence any expression of potassium as a concen-
tration in cell water. Currently, measurements of
the extracellular space in severe disease should be
critically evaluated. It would be better if workers in
this area referred to changes in the volume of distri-
bution of the marker as being the objective measure-
ment, and then considered the possibility that this
may or may not reflect a change in the ECF space.
Fortunately, there are other useful modes of ex-
pression for potassium data which do not require the
measurements of the ECF space. Body or tissue p0-
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Male,g
Male g/kg
Female, g
Female, g/kg
Male, m,nole.s
Female, mmoks
Male, ounoles
Female, imnoles
Male, mow/es
(20 to 29)
M ale, inmoles
(30 to 59)
Female, In/no/es
(20 to 59)
Male, omlo/ec
(20 to 29)
Male, ni/no/es
(30 to 59)
Female, mow/es
(20 to 59)
Male, ozmo/es
(20 to 29)
Male, oimno/e.s
(30 to 59)
Female, n,mo/e,s
(20 to 59)
Both sexes, log10 TBK. wino/es
Both sexes, log0 TBK. oono/es
(1.5 to 27 months)
Males, g
Females. g
Females. g
Males, log TBK. g
Females, log TBK,g
Females, log TBK, g
Both sexes, mob/es
—0.57 X age + 160.4
=
—0.0083 X age + 2.102
=
—0.26 X age 94.4
=
—0.005 X age + 1.58
= 53.0 X ht —9.74 age —5305
= 33.6 X ht —7.73 age —2727
23.96 X wt + 35.15 X ht —12.09 age —3762
= 14.76 X wt + 22.07 X ht 9.05 age —1669
42.8 x hi. —38.71
= 44.4 X ht —4434
= 22.0 >< ht —1267
= 42.4>< wt + 664
= 32.9 >< wt + 840
8.5 X wt + 171
= 21.6 X ht + 29.6 X WI —2226
= 31.0 X ht + 16.8 X wt —3337
9.5± ht + 14.5 X Wt —112
= 6.43 (wt/ht)10 —433,3 Wt/ht2 -—0.49
6.11 (wt/ht)'0 262.82 wt/ht2 —0.2l3LS5 —0.241
= 2.12>< WI + 4.32
= 2.32 X wt —l.50(wI <30kg)
= Ill Xwt+34.9(wt>3Okg)
= 0.0182 x ht + 1.761
= 0.0194± hI + 1.595 (ht < 135 cm)
= 0,0122± ht + 2,574(ht > 135cm)
= 22.66 total RBC K — 596.78
—0.88
—0.95
—0.93
-0.84
0.84
0.81
0.91
0.88
0.64
1.3% 0.74
2.0% 0.46
1.4% 0.70
1.4% 0.68
1.9%
1.3% 0.74
1.2% 0.78
1.9% 0.57
0.34%
0.017 X wt
0.016 X wt
0.013 >< wt
0.007
0.007
0.006
1.12
References [8, 50, 159—162].[S = log0 (l0 — 18), Where ö mean skinfold thickness.
tassium can he related to body wt, lean body mass
(LBM), fat-free dry solids (FFDS), height, creatinine
excretion, and various functions of these measure-
ments. The multiplicity of reference standards that
have been used is eloquent testimony to the unsatis-
factory nature of most of them.
Body wt is the most frequently used, but partic-
ularly in disease the fat and ECF components of the
human body vary greatly. Potassium results, ex-
pressed in terms of body wt, can then be more a
function of a change in the reference standard than in
potassium itself, because both ECF and adipose tis-
sue contribute relatively little potassium to the body.
The lean body mass (LBM) would seem to be a good
choice, but measuring it is difficult as was succinctly
stated by Edelman [64] when he wrote "although the
lean body mass probably is constant in composition
it is bathed in a variable amount of water, held up by
variable supporting structures and-insulated or nour-
ished by extremely variable fat deposits." Subse-
quently, the constancy of the LBM has been ques-
tioned [53, 65—69], and in some diseases, for example,
malnutrition [70], it clearly changes. Nevertheless,
LBM is the least variable reference measurement
available in many situations, and it is the change in
potassium in relation to LBM or its constituents
which is often reported. It is, however, necessary to
measure the adipose tissue of the body in order to
calculate LBM.
Fat or LBM can be measured by underwater
weighing [71—73], by measurement of body volume
and weight [73, 74], by measurement of body water
[75, 76], and in patients with no abnormality of po-
tassium metabolism by measurement of total body
potassium [67, 73, 76—79]. Fat can also be estimated
from height and weight using the regressions estab-
lished between height, weight, and total body water
[67, 75] together with an assumption of the hydration
Table 1. Linear regression equations for prediction of total body potassium (TBK) from functions of age (yr), height (Cmx). Wt (kg). skinlold
thickness (mm), and total red cell potassium (nimo/es)
Regression
Sex, TBK unit of measure. (age range) Equations SFM
-—
coefficient (r'
3.9
0.0 12
l.l3
0.04
.3%
l.0%
1.1%
1.1%
1.5%
(1.93
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Table 2. Distribution volume (liters) of commonly used ECF
markers expressed as a percentage of body wt [351
Sulphate 35 14.6
Inulin 15.6
Thiosulphate 16.3
Mannitol 16.6
Sucrose 17.5
EDTA chromium 51 21.8
Thiocyanate 22.9
Chloride 38 26.8
Bromide 28.4
of the fat-free mass [80]. It is also possible to estimate
body fat from skinfold thickness for which regression
equations appropriate to different ages and sexes
have been published [72] (Table 1). Various combina-
tions of these methods have also been used [67, 73,
81]. In diseased man, each of these methods is based
on assumptions which have not been extensively vali-
dated. The 40K method of measuring fat assumes a
constant potassium content to LBM, while the body
density method assumes a constant density of LBM.
The height/weight method assumes a constant water
content of the fat-free mass. The skinfold method has
been "validated" only by comparison with the other
methods [67, 72]. In healthy animals where direct
comparison of 40K and chemical measurements of fat
have been made, they were reassuringly good [78]
with a correlation coefficient of 0.94. Fat has also
been measured using cyclopropane absorption [82].
This method produced mean differences of less than
1% when compared with chemical analysis in rats.
The method has not been extensively used in man
because of the eight-hour equilibration time, and the
difficulty of avoiding gas leaks [83]. Other gases with
shorter equilibration times have been used of which
radioactive krypton has been most studied. The final
estimate of fat with this method has a potential error
of approximately 10% [84].
Other reference measurements which have been
used to avoid the problem of body fat include height
and creatinine excretion. A correlation coefficient of
0.84 was found for the relationship between TBK and
height in children recovering from malnutrition, a
situation in which body wt can double in eight weeks
[58]. Folin postulated that creatinine excretion would
bear a direct relationship to the active protoplasmic
mass [85]. Subsequent studies [86] demonstrated
linear relationships with high correlation coefficients
between creatinine excretion and body wt, chrono-
logical age, bone age, and height in girls. Height in
boys correlated with creatinine excretion but with a
quadratic rather than linear function because of the
changes of puberty. Creatinine excretion showed
strong linear correlations (r = 0.85) with many of the
components of lean body mass, namely total body
water (TBW), extracellular volume (ECV), total
body chloride (TBC1), total body potassium (TBK)
and intracellular water (ICW). At present there are
still difficulties to all of these methods of arriving at
LBM, and it is, therefore, wise whenever possible to
use a number of reference standards. Some of these
problems are obviated when tissue biopsies are used.
Tissue anal vses: a) Muscle biopsy. Muscle contains
approximately 60% of the body's potassium, so that a
measurement of total muscle potassium will have at
least a crude relationship with TBK. It has been
suggested that body composition studies should be
concerned with muscle as a separate compartment,
and modelling systems to do this have been suggested
[87, 88]. Changes in muscle potassium (mmoles/lOOg
of FFDS) have been used as the reference base for
calculating regression equations to predict potassium
stores [6], but if, as previously noted, there is com-
mensurate negative balance for nitrogen and potas-
sium, muscle potassium (mmoles/l00 g of FFDS)
does not necessarily fall, so that under these circum-
stances muscle potassium (mmoles/lOO g of FFDS) is
not an acceptable guide to potassium balance [27],
but it is an indicator of intracellular potassium con-
centration. In addition, recovery from potassium de-
pletion was noted to be associated with asynchro-
nous changes in potassium and sodium [89], sug-
gesting that the physiology of potassium transport
in muscle may be different from that of other tissues,
i.e., erythrocytes and leukocytes [9, 90]. Acid-base
changes also induce different responses in skeletal
muscle and cardiac muscle, with respiratory acidosis
leading to net potassium uptake in heart and loss in
skeletal muscle [91, 92]. The other problem which
remains is the variation in muscle potassium between
different sites and muscle groups [93—98].
The data on this subject are limited but of great
potential importance. In the normal adult the values
for potassium content of different tissues are not the
same, as Table 3 illustrates. Although some of this
variation results from different proportions of ECF
in the various tissues, it does imply that extrapola-
tions from whole body data to individual organs may
Table 3. Potassium content (ounoles/kg of fat-free wet wt) of
different tissues in adult mans
Skin 23.7
1-leart 66.5
Liver 75.0
Kidney 57.0
Brain 84.6
Muscle 102
a Data from References 97, 98.
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be invalid. Even within one tissue type, muscle, it
has been emphasized that potassium content
(mmoles/l00 g of FFDS) is not constant [931. In
animal studies, a difference of more than 15% has
been found between the potassium content of differ-
ent muscle groups in the same animal, and this was
greater than differences between breeds [94]. The
same pathologic or physiologic stimulus may have
different effects on different tissues, both qualitatively
and quantitatively. For example, protein supplemen-
tation after previous protein and potassium restric-
tion leads to a much greater fall in skeletal muscle
potassium than in cardiac, liver, or kidney potassium
[271. Potassium depletion induced by diet lowers skel-
etal muscle potassium more than cardiac muscle po-
tassium [99]. Anemia is associated with an increase in
erythrocyte potassium (mmoles 100 g of dry solids
[DS]) [100] but has no effect on other tissues. Spe-
cific tissue diseases associated with impairment of
sodium and potassium transport of which many have
been described in the red cell [1011 will he expected to
be associated with potassium depletion in that tissue.
Furthermore, the sensitivity of sodium and potas-
sium activated adenosine triphosphatase (N a- K-AT-
Pase) to ouabain or the proportion of glycoside sensi-
tive transport is different between tissues [9, 90, 102].
Thus, in the assessment of potassium status, the con-
tribution of different tissues to whole body potassium
may differ not only because of their relative weights,
but also because of differences in composition, and in
the functional characteristics of their potassium
transport systems.
Nevertheless, useful information has been obtained
from muscle biopsies in several clinical situations [96,
103, 104]. The techniques, problems, and value of
muscle biopsy have been recently reviewed [40].
b) Muscle mass. Because loss of muscle potassium
is often associated with a loss of muscle mass and
because of the variations between muscle potassium
in individual biopsies, a method for the measurement
of muscle mass has obvious clinical application. The
breakdown of creatine to creatinine is a nonenzymic
process which proceeds at the rate of approximately
2% per day, and it was noted in the last century [105]
that this might allow a calculation of muscle mass
from urinary creatinine. It has been shown that
creatinine excretion follows the development of
muscle rather than age in children with congenital
heart disease [106]. One relationship which has been
proposed is: muscle mass (kg) = urinary creatinine
(g/24 hr) X 20. This figure is approximately correct
but can be individually in error by up to 30% (JAcK-
SON A, personal communication). The largest prob-
lem is variations in dietary creatinine [107, 108]
which can alter urinary creatinine by 20%. Creatine is
also present in the diet but is quantitatively less im-
portant. A change in dietary creatine from zero to 10
g/day can, however, lead to a 20% increase in creati-
nine excretion [109, 110]. Although switching to a
low creatinine diet leads to a new steady state quite
rapidly, changes in dietary creatine are still altering
urinary creatinine at 88 days because of the slow
turnover of creatine [1091. An isotopic method for
measuring muscle mass using creatine nitrogen 15
('5N-creatine) has been published [1111.
Estimation of muscle potassium will therefore pro-
vide diagnostic information in simple potassium defi-
ciency, and combined with muscle mass it can be used
to evaluate a reduced TBK. It will not easily provide
data to establish the diagnosis of potassium defi-
ciency secondary to a transport or membrane defect.
c) Measurement of muscle membrane potential.
Measurement of the resting transmembrane potential
(E-1) in resting muscle has been reported since the
early sixties 112]. Such measurements could the-
oretically be used to calculate muscle potassium ac-
tivity. The results were somewhat variable initially
[62], but a method suitable for use in man was pub-
lished in 1971 [62]. These workers found that in se-
verely ill patients the resting transmembrane poten-
tial was reduced from —88.8 mV to —66.3 mY, and
this was associated with a raised intracellular sodium
but a normal intracellular potassium [62]. There was
also no difference between the potassium content of
muscle from patients who were and were not receiv-
ing cardiac glycosides, unlike the results obtained
from red cells [113]. This clearly raised questions
about the mechanism responsible for the mainte-
nance of intracellular potassium in muscle and also of
the relationship between Em and muscle potassium.
The Em in severely ill patients could not be due to a
change in the sodium-potassium exchange pump, and
it was not predicted by either the Nernst or Goldman
equations. It was suggested that the primary change
was either in the sodium permeability characteristics
of the membrane or the breakdown of an electrogenic
sodium pump, for which there is now good evidence
[114]. Mild potassium deficiency appears normally to
raise the membrane potential in accordance with the
Goldman equation [63, 112, 115] at least in man and
also dog, but in rats there is some conflicting data
with a fall in Em and an increased muscle ECF space
in some studies [115, 116]. In phosphorus deficiency,
intracellular sodium and chloride rose and potassium
fell but by a small amount while the Em fell [117].
Clearly, it is possible to dissociate changes in mem-
brane handling of sodium and potassium in a way
which is not explicable in terms of a change in the
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sodium-potassium exchange pump. What is needed
now are further studies correlating Em changes, and
muscle potassium with potassium measurements in
other tissues.
d) Erythrocytes. For clinical purposes, it would
obviously be advantageous to obtain an estimate of
intracellular potassium from blood. Erythrocytes are
the most easily available, and they have been used for
the measurement of intracellular electrolytes and the
measurement of transport rates for sodium and po-
tassium. There is a large amount of literature on this
subject which was reviewed in 1972 [101]. The meth-
ods are well established and precise. Unfortunately,
the studies which have attempted to correlate red cell
potassium with other important measures of body
potassium [6, 7, 113, 118, 119] have not usually found
a tight correlation. One explanation for this is to be
found in the inverse relationship between hemoglobin
and intracellular potassium [100] which necessitates a
correction factor in diseases associated with anemia
[120]. This is not, however, a total explanation, be-
cause the correlation between red cell potassium con-
centration and TBK is poor even in the absence of
anemia [119]. It has recently been shown, however,
that in normal subjects total body red cell potassium
is highly correlated with total body potassium (r =
0.93). Total plasma potassium is also related to total
body potassium (r = 0.86). The correlations were not
so precise in diabetic subjects [8]. The relationship
between total red cell potassium and TBK is inter-
esting. It seems possible that under normal circum-
stances this relationship follows from the physiologic
relationship between oxygen transport by red cells
and oxygen consumption by the LBM. In normal
man, TBK is a good indicator of LBM, and the
relationship between total hemoglobin and total red
cell potassium is also precise. The regression of TBK
on total red cell potassium is basically a function of
the fact that large people have a large LBM with a
comparably large total red cell mass. The errors in
the measurements of TBK and total red cell potas-
sium are very small compared to the normal range of
body habitus. In disease where other factors affect
both LBM and total red cell mass, one would predict
that the relationship would be less precise as indeed it
is in diabetics [8]. The case studies of Moore et al
[121] suggest that the relationship will not hold in
other disease states.
Erythrocytes have proved extremely valuable as
indicators of conditions in which the transport mech-
anism for sodium and potassium is impaired [101]
and for defining responses to such physiologic
stimuli as acidosis [122].
e) Leukocytes. The leukocyte is a more typical cell
than the red cell in the sense that it has a nucleus and
mitochondria. It appears to have a complex metabo-
lism, which has meant that it can be used to diagnose
a whole range of metabolic disorders [123]. It does,
however, only represent a tiny part of the lean body
mass. As an indicator of potassium stores, it gave the
same overall estimate of degree of depletion in simple
diet and diuretic-induced potassium depletion as bal-
ance studies and exchangable potassium studies [7].
It is, however, important to emphasize that it is a
highly metabolically active cell so that the process of
separation allows time for a new steady state to be
achieved—approximately 40 mm. [124]. The leu-
kocyte potassium transport system, like that of the
red cell [90], is very sensitive to external potassium,
particularly in the hypolkalemic range, so that if the
cells are washed and resuspended in media of differ-
ent potassium concentration, intracellular potassium
will be changed. Methods for the measurement of
leukocyte electrolytes and sodium and potassium
transport have been described [124—127].
It is only in isolated cells that potassium transport
can currently be measured in clinical situations.
From a practical point of view, the leukocyte trans-
port system is some 75 times faster than the eryth-
rocyte system, so that results can be obtained more
quickly and diminished activity detected more easily.
The methods are not yet as precise as those used for
the red cell, nor can leukocytes be measured in a
routine laboratory, whereas red cells can. In both
erythrocytes and leukocytes, intracellular potassium
concentration in cell water can be measured easily
and precisely, which is not true of any other method-
ology.
An approach to clinical potassium deficiency
In view of the different information which can be
obtained from the various methodologies for the ap-
praisal of potassium stores, a brief classification of
potassium depletion is presented and the methods
appropriate to each group indicated.
Classification of potassium depletion: 1) Lowering
of potassium concentration in ECF and ICF but
appropriately related, 2) lowering of intracellular
potassium but inappropriately related to ECF potas-
sium, and 3) lowering of TBK with little or no
change in potassium concentration (This has been
termed "diminished potassium capacity" [24] or
"pseudo-depletion" [32]). These groups are not en-
tirely separable as the following discussion will illus-
trate, but this approach to the assessment of potas-
sium stores is from a physiologic viewpoint and also
indicates appropriate lines of treatment. Type I rep-
resents "simple" negative balance for potassium,
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which is corrected by provision of potassium supple-
ments. Type 2 results from the effects of disease on
membrane function. Alterations in passive perme-
ability and active transport have been described
[33—36, 101, 126, 128—137]. This group also includes
the disturbances of potassium associated with acid-
base disorders. Type 3 represents the effect of loss of
LBM without alteration in the remaining tissues.
This process may lead on to type 2 when it is severe,
for example, in severe malnutrition [135].
The use of the terms "appropriately" and "in-
appropriately" needs amplification. In vitro experi-
ments show that external potassium stimulates potas-
sium influx in both red cells and leukocytes [1, 9, 90]
(Figs. 1 and 2), but effiux is less affected. Therefore,
there are also increases in intracellular potassium
(Fig. 3). The relationship is curvilinear but can be
described by a straight line in the physiologic range.
Both Welt ct al [61, using rats, and Bergstrom and
1-lultman [5], using dialyzed patients, have reported a
linear relationship between plasma potassium and
muscle potassium, but they did not study very low
ECF potassium values. In vitro, and probably in vivo,
if the only abnormality is negative potassium balance
of relatively short duration with a steady low plasma
potassium, it should lead to a predictable intracellu-
lar potassium. If the measured value is different from
the predicted, it implies the presence of other fac-
tors producing an alteration in membrane function.
Uremia is a clear example where, despite high plasma
potassium values, many studies have indicated a nor-
mal or low value for TBK, or tissue potassium.
Transport abnormalities have been demonstrated in
both erythrocytes and leukocytes [33—361 obtained
from uremic patients.
One of the most clearly documented causes of in-
appropriate relationships between ECF potassium
and ICF potassium is an acid-base disturbance. This
is a complex subject with interrelations between acid-
base state, sodium balance, and potassium. Darrow
et al showed a long while ago [163] that there was an
inverse relationship between ECF bicarbonate and
intracellular potassium. Furthermore, he demon-
strated that this relationship could be altered by
coincident chloride or sodium depletion. The com-
plexities of' the relationship between intracellular p0-
tassium concentration and hydrogen ion are consid-
ered in detail elsewhere in this symposium [164]. It is
sufficient for the present purpose to note that acid-
base disturbances are one cause of an inappropriate
relationship between intracellular and extracellular
potassium.
The approach described above is certainly too sim-
plistic as anything more than an initial attempt to
define feasible ways to diagnose transport defects. It
is presented as a concept which may be helpful rather
than as an established fact. Even the behavior of the
basic sodium-potassium exchange pump is still being
elucidated in normal cells without introducing the
added complexities of disease processes. This so-
dium-potassium pump can be made to operate in five
different modes, namely sodium-potassium exchange,
sodium-sodium exchange, potassium-potassium ex-
change, sodium effiux without potassium influx, and
a reversed mode [138]. Furthermore, there are differ-
ences between tissues, for example, in the proportion
ofglycoside sensitive: insensitive transport (Fig. 1) [9,
90]. If, as appears to be the case, the system normally
works with a fixed stoichemiometry between milli-
moles of sodium and potassium transported, then
this will also have implications for potential effects of
alterations in sodium permeability on intracellular
potassium. The effect of inhibitors of the sodium
pump, for example, cardiac glycosides, in producing
potassium depletion can take several days to reach a
steady state [113], so that depending upon the time
and tissue used for sampling, different effects will be
observed. There is some evidence that these changes
can be reversed to a small degree [131], although the
therapeutic effect of digoxin is probably dependent
upon altered intracellular electrolytes [139]. Finally,
alterations in potassium stores consequent upon acid-
base metabolism are not clearly worked out, and they
change with time and from tissue to tissue. The ef-
fects on the kidney are probably of paramount im-
portance.
Comparison of the dtfferent methods of assessment
of potassium stores in clinical situations with different
types of potassium deficiency. I) Simple potassium
deficiency. Experimental studies have demonstrated
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that similar but not quantitatively identical changes
in potassium stores can be derived from all of the
methods discussed (Fig. 3). Even the much maligned
plasma potassium was found to be useful in two
studies [6, 7]. These studies used diet with additional
DOCA or diuretics to induce potassium deficiency.
There are some exceptions which should be noted.
Anemia will negate the usefulness of red cell potas-
sium unless a correction is used. Cardiac muscle
seems to have a mechanism which protects it against
potassium depletion [99].
2) Complex potassium deficiency. Severe malnutri-
tion presents some of the most complex metabolic
disturbances in medicine, and its treatment can pro-
duce dramatic changes in body composition. For ex-
ample, a child with severe kwashiorkor, weighing 5 to
7 kg, may lose 2 kg of edema in a week and then
double his body wt in a further six weeks.
In severe malnutrition the presence of potassium
depletion has been established by balance measure-
ments [14, 19], whole body counting [141, 142], total
exchangeable potassium measurements [14, 143],
analysis of muscle [70, 144] (Fig. 4), and other tissues
[145, 146]. Analysis of cadavers has also shown that
the potassium depletion is associated with an increase
in total body sodium regardless of the presence or
absence of edema [147]. Plasma potassium may be
increased, reduced, or normal [148]. Thus, in most
cases the relationship between plasma potassium and
intracellular potassium is inappropriate in terms of
Figure 2. Thus, potassium depletion in malnutrition
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is compounded of a low intracellular potassium con-
centration and a reduced LBM, indicated by gross
wasting. Significant retention of potassium continues
for some 2 to 3 weeks of treatment [19, 141], but
initially high rates of potassium supplementation
lead to high urinary potassium values with little re-
tention [14]. All the tissues of the body are not sim-
ilarly depleted, muscle being disproportionately de-
pleted, while the visceral tissues are spared [145].
Thus, the correlation between whole body potassium
and muscle potassium is relatively poor with correla-
tion coefficients of around 0.5 with wide 95% con-
fidence limits [104]. The relationship is also non-
linear (Fig. 4).
Measurements in leukocytes of transport rates for
sodium and intracellular electrolytes demonstrated
abnormalities in sodium transport. Recovery from
nonedematous malnutrition was associated with a
rise in intracellular potassium, a fall in intracellular
sodium, and an increase in ouabain-sensitive sodium
effiux over a period of at least three weeks (Fig. 5). In
this condition, therefore, all the various methods of
assessment of potassium stores have contributed to a
picture which none could give alone. All three types
of potassium depletion may occur in severe malnutri-
tion. Thus, for example, in areas where gastroente-
ntis is an almost invariable accompaniment of severe
malnutrition, the initial correction of simple negative
balance for potassium with potassium supplementa-
tion has been emphasized [149], whereas with rela-
tively "pure" malnutrition the prolonged time course
associated with the transport defect and the resyn-
thesis of LBM is more apparent [70].
400 - Potassium physiology in uremia, which is discussed
elsewhere in this issue, presents a similarly complex
situation in that high, normal and low values have
T been reported for whole body or cellular potassium
300 - I t [29, 150—158].Conclusion. The variety of methods used for the
assessment of potassium status in man are evidence
of the difficulties which are involved. For simple
200 - negative balance of potassium, there seem to be few
qualitative differences between the methods, with the
solitary exception of the data derived from anemic
red cells.
100 For pure loss of LBM without any other defect,
N - 8 only whole body counting, or balance data, will dem-
50 I I I onstrate potassium deficiency.
25 30 45 50 Pure loss of potassium capacity rarely occurs, in
that whole tissue is rarely lost. For instance, in
muscle wasting the supporting collagen framework
tends to remain, so that muscle biopsy shows a re-
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Fig. 4. The relationship between total body potassium (TBK) mea-
sured by 40K whole body counting and muscle potassium in chil-
dren with severe malnutrition. The TBK values are grouped in
steps of 5 mmoles/kg. SCM are given for the muscle data [701.
marker, which in disease may measure much larger
volumes. Potassium content based on 40K measure-
ments remains a precise measurement, but its inter-
pretation is dependent upon the method used to de-
fine the normal range and the assumption that all the
tissues of the body behave similarly. The equations
used to predict the normal range may not all be
applicable to disease states. Equations based on
height are the safest. Unfortunately, the predicted
normal range for a given individual is about
Isolated cell preparations offer the only currently fea-
sible method of measuring the physiology of potas-
sium transport in disease. These methods, however,
are essentially 'in vitro" measurements, and the ef-
fects of hormones and other short half-life substances
which interact with the transport processes are lost.
Muscle appears to be the most representative tissue
to biopsy, in that most of the body potassium is in
muscle, but essential organs may well behave differ-
ently. The variation between muscle groups and the
problem of measuring the extracellular space also
present technical and interpretive problems. A com-
bination of these various methods seems to be the
most sensible approach for the present, with the hope
that measurement of membrane potentials and the
development of electron probes may give us more
precise tools in the future. In the interval some more
cadaver studies with careful discrimination between
the contributions of different tissues would be im-
mensely valuable.
Reprint requests 10 Dr. John Patrick, Tropical Metabolism Re-
search Coil, Unicersit o/ the West Indies, A.ingston 7, Jamaica.
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Fig. 5. .4 Iterations in intracellular polassiu,n (A) (P < 0.0/) and the
g/tcoside-sensilwe efflux rate for sodium (B) (P < 0.01) during
recnvert fio,n severe ,nalnuir,t ion, measured in leukocytes in vitro.
PEM — protein energy malnutrition.
Marked wasting will eventually lead to a low
TBK/kg of body wt because of the increasing impor-
tance of the skeleton.
In more prolonged and metabolically complex po-
tassium deficiency, plasma potassium is very unre-
liable, and attempts to measure intracellular potas-
sium concentrations by combination of whole body
counting and measurement of the ECF space are
dependent upon the distribution volume of the
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